EP 1100526 A2 20010523 - USE OF HC gp-39 IN IMMUNE DISEASES
Title (en)
USE OF HC gp-39 IN IMMUNE DISEASES
Title (de)
VERWENDUNG VON HC GP-39 IN IMMUNERKRANKUNGEN
Title (fr)
UTILISATION DE gp-39 DE CARTILAGE HUMAIN DANS DES MALADIES IMMUNES
Publication
Application
Priority
- EP 99938340 A 19990719
- EP 9905331 W 19990719
- EP 98202471 A 19980723
Abstract (en)
[origin: WO0004917A2] The present invention relates to the use of HC gp-39 to prevent inflammatory diseases. More specifically, HC gp-39 or fragments thereof can be used to modulate the reactivity of lymphocytes which are reactive to antigens other than HC gp-39 but which are present in the same tissue as where HC gp-39 is being expressed.
IPC 1-7
IPC 8 full level
A61K 39/00 (2006.01); A61K 38/17 (2006.01); A61P 29/00 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 38/1709 (2013.01); A61P 29/00 (2017.12); A61P 37/02 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 0004917A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0004917 A2 20000203; WO 0004917 A3 20000720; WO 0004917 A9 20000824; AU 5287599 A 20000214; EP 1100526 A2 20010523; JP 2002521344 A 20020716
DOCDB simple family (application)
EP 9905331 W 19990719; AU 5287599 A 19990719; EP 99938340 A 19990719; JP 2000560910 A 19990719